Pre-treatment Exercises Versus Post-treatment Exercises for Dysphagia
Sponsor
University of Alabama at Birmingham (Other)
Overall Status
Completed
CT.gov ID
NCT00584129
Collaborator
American Academy of Otolaryngology-Head and Neck Surgery Foundation (Other)
52
1
2
106
0.5
Study Details
Study Description
Brief Summary
The purpose of this project is to determine if pre-treatment swallowing exercises can improve post-treatment swallowing function in patients undergoing radiation with or without chemotherapy for advanced squamous cell carcinoma of the head and neck.
Condition or Disease | Intervention/Treatment | Phase |
---|---|---|
|
N/A |
Study Design
Study Type:
Interventional
Actual Enrollment
:
52 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
None (Open Label)
Primary Purpose:
Supportive Care
Official Title:
Determining the Efficacy of Pre-treatment Swallowing Therapy as a Means to Improve Dysphagia Quality of Life When Compared to Post-Treatment Therapy.
Study Start Date
:
Feb 1, 2006
Actual Primary Completion Date
:
Dec 1, 2013
Actual Study Completion Date
:
Dec 1, 2014
Arms and Interventions
Arm | Intervention/Treatment |
---|---|
Experimental: 1 Patients will receive pre-treatment swallowing exercises. |
Other: Pre-treatment swallowing exercises
Swallowing exercises will be started pre-treatment with radiation.
|
Active Comparator: 2 Post-treatment swallowing exercises. |
Other: Post-treatment swallowing exercises.
Patients to start swallowing exercises after completion of radiation therapy.
|
Outcome Measures
Primary Outcome Measures
- To test whether pre-treatment swallowing exercises compared with "usual care" (where exercises are taught post-treatment) improves quality of life in patients undergoing chemoradiation therapy for advanced head and neck cancer. [8 weeks, 6 months, 12 months post radiation treatment]
Secondary Outcome Measures
- To test whether pre-treatment swallowing exercises compared with usual care improves secondary outcome measures related to dysphagia in this patient population. [8 weeks, 6 mnths and 12 months post radiation.]
Eligibility Criteria
Criteria
Ages Eligible for Study:
19 Years
and Older
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
-
Stage III or IV squamous cell cancer of teh pharynx and larynx
-
Patients who will be receiving chemoradiation
-
Age 19 years of age or older
-
Must sign informed consent.
Exclusion Criteria:
-
Prior cancer diagnosis
-
Metastatic disease
-
Cognitive Impairment
Contacts and Locations
Locations
Site | City | State | Country | Postal Code | |
---|---|---|---|---|---|
1 | UAB Division of Otolaryngology | Birmingham | Alabama | United States | 35294 |
Sponsors and Collaborators
- University of Alabama at Birmingham
- American Academy of Otolaryngology-Head and Neck Surgery Foundation
Investigators
- Principal Investigator: William R. Carroll, MD, University of Alabama at Birmingham
Study Documents (Full-Text)
None provided.More Information
Publications
None provided.Responsible Party:
William Carroll, MD,
Professor of Surgery,
University of Alabama at Birmingham
ClinicalTrials.gov Identifier:
NCT00584129
Other Study ID Numbers:
- F060123002
- F060123002
First Posted:
Jan 2, 2008
Last Update Posted:
Mar 17, 2015
Last Verified:
Mar 1, 2015
Keywords provided by William Carroll, MD,
Professor of Surgery,
University of Alabama at Birmingham
Additional relevant MeSH terms: